Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Popovic

Showing results (131-140 of 304) with videos related to

Pageof 31
Sort By:
World Journal of Diabetes|April 29, 2024
Effect of special types of bread with select herbal components on postprandial glucose levels in diabetic patientsDrasko M Gostiljac, Srdjan S Popovic, Vesna Dimitrijevic-Sreckovic, et al.
Future Cardiology|March 18, 2025
Treatment options for heart failure in individuals with overweight or obesity: a reviewAthina Nasoufidou, Panagiotis Stachteas, Paschalis Karakasis, et al.
Minerva Cardiology and Angiology|February 24, 2026
Presepsin as a biomarker of coronary artery disease in type 2 diabetes along the immune-inflammatory continuumDimitrios Kouroupis, Theodora M Stougiannou, Ioanna Zografou, et al.
Current Vascular Pharmacology|February 4, 2017
Surrogates of Insulin Sensitivity and Indices of Cardiometabolic Profile in ObesityDjordje S Popovic, Edita Stokic, Milena Mitrovic, et al.
Methods and Findings in Experimental and Clinical Pharmacology|December 7, 2010
Observational study of patients switched to the fixed travoprost 0.004%/timolol 0.5% combination in CroatiaZ Mandic, K Novak-Lauš, L Bojic, et al.
Acta Endocrinologica (Bucharest, Romania : 2005)|December 20, 2021
THE EFFECT OF MYOINOSITOL AND METFORMIN ON CARDIOVASCULAR RISK FACTORS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME: A RANDOMIZED CONTROLLED TRIALV Soldat-Stankovic, S Popovic Pejicic, S Stankovic, et al.
Current Neurovascular Research|June 20, 2017
The Wnt/β-catenin Signalling Pathway Inhibitor Sclerostin is a Biomarker for Early Atherosclerosis in ObesityDjordje S Popovic, Milena Mitrovic, Dragana Tomic-Naglic, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 23, 2021
Clinical Benefit of Insulin Glargine 300 U/mL Among Patients with Type 2 Diabetes Mellitus Previously Uncontrolled on Basal or Premixed Insulin in Serbia: A Prospective, Observational, Single-Arm, Multicenter, Real-World StudyMilena Velojic-Golubovic, Vojislav Ciric, Marija Dimitrijevic, et al.
Medicina (Kaunas, Lithuania)|November 27, 2025
SGLT2 Inhibitors in the Management of Cardio-Renal-Metabolic Syndrome: A New Therapeutic EraKonstantinos Grigoriou, Paschalis Karakasis, Athina Nasoufidou, et al.
Oncology Research|July 26, 2024
Pharmacological methods for ovarian function and fertility preservation in women with cancer: A literature reviewAna S Cvetanovic, Matteo Lambertini, Kevin Punie, et al.
Pageof 31

Showing results (131-140 of 304) with videos related to

Sort By:
Pageof 31
World Journal of Diabetes|April 29, 2024
Effect of special types of bread with select herbal components on postprandial glucose levels in diabetic patientsDrasko M Gostiljac, Srdjan S Popovic, Vesna Dimitrijevic-Sreckovic, et al.
Future Cardiology|March 18, 2025
Treatment options for heart failure in individuals with overweight or obesity: a reviewAthina Nasoufidou, Panagiotis Stachteas, Paschalis Karakasis, et al.
Minerva Cardiology and Angiology|February 24, 2026
Presepsin as a biomarker of coronary artery disease in type 2 diabetes along the immune-inflammatory continuumDimitrios Kouroupis, Theodora M Stougiannou, Ioanna Zografou, et al.
Current Vascular Pharmacology|February 4, 2017
Surrogates of Insulin Sensitivity and Indices of Cardiometabolic Profile in ObesityDjordje S Popovic, Edita Stokic, Milena Mitrovic, et al.
Methods and Findings in Experimental and Clinical Pharmacology|December 7, 2010
Observational study of patients switched to the fixed travoprost 0.004%/timolol 0.5% combination in CroatiaZ Mandic, K Novak-Lauš, L Bojic, et al.
Acta Endocrinologica (Bucharest, Romania : 2005)|December 20, 2021
THE EFFECT OF MYOINOSITOL AND METFORMIN ON CARDIOVASCULAR RISK FACTORS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME: A RANDOMIZED CONTROLLED TRIALV Soldat-Stankovic, S Popovic Pejicic, S Stankovic, et al.
Current Neurovascular Research|June 20, 2017
The Wnt/β-catenin Signalling Pathway Inhibitor Sclerostin is a Biomarker for Early Atherosclerosis in ObesityDjordje S Popovic, Milena Mitrovic, Dragana Tomic-Naglic, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 23, 2021
Clinical Benefit of Insulin Glargine 300 U/mL Among Patients with Type 2 Diabetes Mellitus Previously Uncontrolled on Basal or Premixed Insulin in Serbia: A Prospective, Observational, Single-Arm, Multicenter, Real-World StudyMilena Velojic-Golubovic, Vojislav Ciric, Marija Dimitrijevic, et al.
Medicina (Kaunas, Lithuania)|November 27, 2025
SGLT2 Inhibitors in the Management of Cardio-Renal-Metabolic Syndrome: A New Therapeutic EraKonstantinos Grigoriou, Paschalis Karakasis, Athina Nasoufidou, et al.
Oncology Research|July 26, 2024
Pharmacological methods for ovarian function and fertility preservation in women with cancer: A literature reviewAna S Cvetanovic, Matteo Lambertini, Kevin Punie, et al.
Pageof 31